Clinical Trial Update: Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial update on bioprofiling response to mineralocorticoid receptor antagonists for prevention of heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: ACS Biomarker | Conditions: Heart Failure | Phase 2 | Status: COMPLETED